Corcept Therapeutics reported $111.06M in Trade Debtors for its fiscal quarter ending in September of 2026.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 178.32M 11.98M Sep/2026
Alaunos Therapeutics USD 2K 0 Jun/2025
ANI Pharmaceuticals USD 304.45M 29.98M Sep/2026
Ardelyx USD 100.35M 17.51M Jun/2026
Aurora Cannabis CAD 41.09M 3.49M Jun/2026
BioMarin Pharmaceutical USD 1.08B 15.31M Sep/2026
Bristol-Myers Squibb USD 12.85B 976M Sep/2026
Canopy Growth CAD 42.59M 6.3M Jun/2026
Corcept Therapeutics USD 111.06M 34.14M Sep/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
J&J USD 19.05B 3.49B Jun/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
Lexicon Pharmaceuticals USD 2.38M 50K Dec/2025
Merck USD 12.56B 354M Jun/2026
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Novartis USD 9.96B 109M Sep/2026
Novartis USD 9.96B 361M Sep/2026
Omeros USD 8.08M 440K Jun/2024
Pfizer USD 17.57B 1.38B Sep/2026
Supernus Pharmaceuticals USD 211.66M 29.47M Jun/2026
TG Therapeutics USD 416.82M 15.26M Sep/2026